Allergan Shares Down 6%; Co. Earlier Issued Release Highlighting Suspension Of Sales, Withdrawal Of Supply Of Textured Breast Implants In Europe; Hearing JP Morgan Issued Report 'Breast Implant Related Sell-off Appears Overdone'